Hypaque-m,90% and Racing thoughts - a phase IV clinical study of FDA data
We study 31 people who take Hypaque-m,90% or have Racing thoughts. No report of Racing thoughts is found in people who take Hypaque-m,90%.
The phase IV clinical study is created by eHealthMe based on reports from the FDA, and is updated regularly.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
No report is found.
What is Hypaque-m,90%?
Hypaque-m,90% has active ingredients of diatrizoate meglumine; diatrizoate sodium.
What is Racing Thoughts?
Racing thoughts: no further information found.
Do you take Hypaque-m,90% and have Racing thoughts?Check whether Racing thoughts is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
How severe was Racing thoughts and when was it recovered:
Expand to all the drugs that have ingredients of diatrizoate meglumine; diatrizoate sodium:
Alternative drugs to, pros and cons of Hypaque-m,90%:
Racing thoughts treatments and more:
- Racing thoughts (31 reports)
COVID vaccines that are related to Racing thoughts:
- Racing thoughts in Moderna COVID Vaccine
- Racing thoughts in Pfizer BioNTech Covid Vaccine
- Racing thoughts in Johnson and Johnson Covid Vaccine
All the drugs that are associated with Racing thoughts:
All the conditions that are associated with Racing thoughts:
How the study uses the data?
The study uses data from the FDA. It is based on diatrizoate meglumine; diatrizoate sodium (the active ingredients of Hypaque-m,90%) and Hypaque-m,90% (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Omacor and Simvastatin drug interaction - 5 seconds ago
- Ceftriaxone and Synovial Sarcoma - 7 seconds ago
- Cipro and Oropharyngeal Discomfort - 8 seconds ago
- Brilinta and Atrial Fibrillation Aggravated - 9 seconds ago
- Prevpac and Movement - Uncontrolled Or Slow - 17 seconds ago
- Zoloft and Gallbladder Perforation - 17 seconds ago
- Xarelto and Oesophageal Adenocarcinoma - 18 seconds ago
- Boron and Intervertebral Disc Degeneration - 18 seconds ago
- Palynziq and Colecalciferol drug interaction - 32 seconds ago
- Mometasone Furoate and Small Intestinal Obstruction - 32 seconds ago